Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound

NCT00655512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: pimecrolimus 1% cream
DRUG: hydrocortisonacetat 1% cream
DRUG: betamethasonvalerat 0,1% cream
DRUG: clobetasol-17-propionat 0,05% cream
DRUG: Placebo

Sponsor

Technische Universität Dresden